Triapine: all 33 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaRecruitingNCT06860594Phase 1
• Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine TumorsActive, not recruitingNCT04234568Phase 1Results posted
• Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal CancerActive, not recruitingNCT02595879Phase 1Results posted
• Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal CancersActive, not recruitingNCT02466971Phase 3Results posted
• Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal CancerCompletedNCT00941070Phase 2Results posted
• 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00381550Phase 2Results posted
• Triapine and Gemcitabine Hydrochloride in Gallbladder CancerCompletedNCT00075504Phase 2Results posted
• Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine TumorsActive, not recruitingNCT05724108Phase 2
• Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyActive, not recruitingNCT04494113Early Phase 1
• 3-AP in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00390052Phase 1
• Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic MalignanciesCompletedNCT00335998Phase 1
• 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00293345Phase 1
• 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00288093Phase 1
• 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerTerminatedNCT00095888Phase 2
• Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00085371Phase 2
• Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00084877Phase 1
• 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00081276Phase 2
• 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid TumorsCompletedNCT00079014Phase 1
• 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00078975Phase 2
• 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00077558Phase 1
• 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionCompletedNCT00077545Phase 2
• 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00077415Phase 2
• A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung CancerCompletedNCT00077350Phase 2
• 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic MalignanciesCompletedNCT00077181Phase 1
• 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell CarcinomaCompletedNCT00075660Phase 2
• 3-AP and Cytarabine in Treating Patients With Hematologic CancerCompletedNCT00064090Phase 1
• 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00064064Phase 2
• 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00064051Phase 2
• 3-AP in Treating Patients With Advanced Prostate CancerCompletedNCT00054015Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00024323Phase 1
• 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic CancerCompletedNCT00016874Phase 1
• 3-AP in Treating Patients With Advanced CancerCompletedNCT00006218Phase 1
• 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid TumorsCompletedNCT00004213Phase 1

← Triapine overview